Table:
begin	end	state
1	26	cytoplasmic
27	45	transmembrane
46	65	non-cytoplasmic
66	84	transmembrane
85	95	cytoplasmic
96	114	transmembrane
115	118	non-cytoplasmic
119	143	transmembrane
144	155	cytoplasmic
156	179	transmembrane
180	184	non-cytoplasmic
185	203	transmembrane
204	245	cytoplasmic
246	268	transmembrane
269	285	non-cytoplasmic
286	309	transmembrane
310	320	cytoplasmic
321	339	transmembrane
340	344	non-cytoplasmic
345	367	transmembrane
368	376	cytoplasmic
377	400	transmembrane
401	406	non-cytoplasmic
407	431	transmembrane
432	439	cytoplasmic

Input:
>17727 FitnessBrowser__Keio:17727
MLPFLKAPADAPLMTDKYEIDARYRYWRRHILLTIWLGYALFYFTRKSFNAAVPEILANG
VLSRSDIGLLATLFYITYGVSKFVSGIVSDRSNARYFMGIGLIATGIINILFGFSTSLWA
FAVLWVLNAFFQGWGSPVCARLLTAWYSRTERGGWWALWNTAHNVGGALIPIVMAAAALH
YGWRAGMMIAGCMAIVVGIFLCWRLRDRPQALGLPAVGEWRHDALEIAQQQEGAGLTRKE
ILTKYVLLNPYIWLLSFCYVLVYVVRAAINDWGNLYMSETLGVDLVTANTAVTMFELGGF
IGALVAGWGSDKLFNGNRGPMNLIFAAGILLSVGSLWLMPFASYVMQATCFFTIGFFVFG
PQMLIGMAAAECSHKEAAGAATGFVGLFAYLGASLAGWPLAKVLDTWHWSGFFVVISIAA
GISALLLLPFLNAQTPREA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server